Organisation paid for research Program year 2025 Source: CMS Open Payments

eMD Alliance Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$470,997

74 payments

Through program year 2025, eMD Alliance Research, LLC is reported as receiving $470,997 in research payments, across 74 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$6,290	3
2024	Research	$12,798	4
2023	Research	$143,637	5
2022	Research	$79,900	14
2021	Research	$142,112	23
2020	Research	$23,074	9
2019	Research	$63,186	16

Breakdown

Who paid Research payments · program years 2019–2025

MicroPort Orthopedics Inc $294,136 11 payments
Zimmer Biomet Holdings, Inc. $116,447 40 payments
Conformis, Inc. $59,488 22 payments
Exactech, Inc. $926 1 payment

Studies the money was for Research payments · program years 2019–2025

Kinematic Analysis of Robotic Assisted TKA during Functional Activities $118,779 1 payment
Long Term Evolution Post Market Clinical Follow-up $69,915 3 payments
MGH E1 Tibial Bearing with Vanguard Knee $58,325 12 payments
Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty stem for Total Hip Arthroplasty $54,122 27 payments
Long-term Evolution Post-Marketing Clinical Follow-up (PMCF) $49,930 2 payments
Data Mining on Evolution Revision Tibia $47,128 2 payments
iTotal Identity 20-001 $26,220 7 payments
iTotal 12-001 $25,000 8 payments
Evaluation of Quadriceps Strength and Functional Outcomes After Total Knee Replacement $5,560 2 payments
Conformis Hip 18-001 $4,439 5 payments

What the money was spent on Research payments · program years 2019–2025

Patient care $97,058 4 payments
Overhead $55,490 4 payments
Medical research writing or publication $33,450 12 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.